Electrophysiology Ablation Catheters – Medical Devices Pipeline Assessment, 2020

An Electrophysiology Ablation Catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm. GlobalData's Medical Devices sector report, “Electrophysiology Ablation Catheters-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Electrophysiology Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Electrophysiology Ablation Catheters Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Electrophysiology Ablation Catheters under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Electrophysiology Ablation Catheters pipeline products.

Review of Recent Developments in the segment / industry

The Electrophysiology Ablation Catheters Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Electrophysiology Ablation Catheters- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Electrophysiology Ablation Catheters under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Abbott Electrophysiology

Ablacon Inc

Apama Medical Inc

Biosense Webster Inc

BioTex Inc

Boston Scientific Corp

CardioNova Ltd

CathEffects LLC

CathRx Ltd

Cibiem Inc

Columbia University

Cordis Corp

CoreMap Inc

CPSI Biotech

CryoTherapeutics Gmbh

Epicardial Technologies Inc (Inactive)

Eximo Medical Ltd

Farapulse Inc

FocusStart LLC

Hyblate Medical

Imricor Medical Systems Inc

Interventional Imaging, Inc.

Iowa Approach Inc.

Maestro Heart SA

Medlumics SL

Medtronic Plc

MedWaves Inc

MicroPort Scientific Corp

Northwestern University

Novasentis Inc

S4 Medical Corp

SCR, Inc.

Seattle Children's Hospital

St. Jude Medical LLC

Stereotaxis Inc

University of Arkansas at Little Rock

University of Michigan

University of Rochester

University of Texas Medical Branch at Galveston

Vanderbilt University

Vimecon GmbH

Vivonics Inc

Voyage Medical (Inactive)

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 8

2 Introduction 9

2.1 Electrophysiology Ablation Catheters Overview 9

3 Products under Development 10

3.1 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 10

3.2 Electrophysiology Ablation Catheters – Pipeline Products by Segment 11

3.3 Electrophysiology Ablation Catheters – Pipeline Products by Territory 12

3.4 Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 13

3.5 Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 14

3.6 Electrophysiology Ablation Catheters – Ongoing Clinical Trials 15

4 Electrophysiology Ablation Catheters – Pipeline Products under Development by Companies 16

4.1 Electrophysiology Ablation Catheters Companies – Pipeline Products by Stage of Development 16

4.2 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 18

5 Electrophysiology Ablation Catheters Companies and Product Overview 20

5.1 Abbott Electrophysiology Company Overview 20

5.1.1 Abbott Electrophysiology Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Ablacon Inc Company Overview 23

5.2.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.3 Apama Medical Inc Company Overview 24

5.3.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 Biosense Webster Inc Company Overview 25

5.4.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 BioTex Inc Company Overview 31

5.5.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.6 Boston Scientific Corp Company Overview 32

5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 CardioNova Ltd Company Overview 39

5.7.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.8 CathEffects LLC Company Overview 40

5.8.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 40

5.9 CathRx Ltd Company Overview 41

5.9.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.10 Cibiem Inc Company Overview 44

5.10.1 Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.11 Columbia University Company Overview 47

5.11.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 47

5.12 Cordis Corp Company Overview 48

5.12.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 48

5.13 CoreMap Inc Company Overview 49

5.13.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.14 CPSI Biotech Company Overview 50

5.14.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 50

5.15 CryoTherapeutics Gmbh Company Overview 52

5.15.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 52

5.16 Epicardial Technologies Inc (Inactive) Company Overview 53

5.16.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53

5.17 Eximo Medical Ltd Company Overview 54

5.17.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.18 Farapulse Inc Company Overview 55

5.18.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.19 FocusStart LLC Company Overview 60

5.19.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 60

5.20 Hyblate Medical Company Overview 61

5.20.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 61

5.21 Imricor Medical Systems Inc Company Overview 62

5.21.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.22 Interventional Imaging, Inc. Company Overview 63

5.22.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63

5.23 Iowa Approach Inc. Company Overview 64

5.23.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 64

5.24 Maestro Heart SA Company Overview 67

5.24.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 67

5.25 Medlumics SL Company Overview 68

5.25.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 68

5.26 Medtronic Plc Company Overview 69

5.26.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 69

5.27 MedWaves Inc Company Overview 73

5.27.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.28 MicroPort Scientific Corp Company Overview 74

5.28.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 74

5.29 Northwestern University Company Overview 76

5.29.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 76

5.30 Novasentis Inc Company Overview 77

5.30.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.31 S4 Medical Corp Company Overview 78

5.31.1 S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 78

5.32 SCR, Inc. Company Overview 79

5.32.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79

5.33 Seattle Children's Hospital Company Overview 80

5.33.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 80

5.34 St. Jude Medical LLC Company Overview 81

5.34.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 81

5.35 Stereotaxis Inc Company Overview 85

5.35.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.36 University of Arkansas at Little Rock Company Overview 87

5.36.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 87

5.37 University of Michigan Company Overview 88

5.37.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 88

5.38 University of Rochester Company Overview 89

5.38.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 89

5.39 University of Texas Medical Branch at Galveston Company Overview 90

5.39.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 90

5.40 Vanderbilt University Company Overview 92

5.40.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 92

5.41 Vimecon GmbH Company Overview 93

5.41.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 93

5.42 Vivonics Inc Company Overview 94

5.42.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.43 Voyage Medical (Inactive) Company Overview 95

5.43.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95

6 Electrophysiology Ablation Catheters- Recent Developments 96

6.1 Sep 17, 2020: CIRSE 2020: New clinical data support use of 4-french devices for ambulatory pad treatment 96

6.2 Aug 04, 2020: Imricor announces first sales collaboration with Philips 96

6.3 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical 97

6.4 May 19, 2020: Cathvision completes new investment round of a total 13M Euro 98

6.5 May 15, 2020: Microport orthopedics group brings in new strategic investors 98

6.6 May 07, 2020: FARAPULSE's pioneering clinical results link compelling long-term outcomes to established safety and lesion durability data 99

6.7 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 100

6.8 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019 101

6.9 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 101

6.10 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 102

6.11 Feb 18, 2020: Medtronic reports third quarter financial results 2020 102

6.12 Feb 05, 2020: Imricor announces first cases successfully performed at Heart Center Dresden 105

6.13 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 105

6.14 Feb 02, 2020: First cases successfully performed at Heart Center Dresden 107

6.15 Jan 30, 2020: FARAPULSE extensively showcased at leading AF Symposium 107

6.16 Jan 28, 2020: Imricor receives CE Mark approval for Vision-MR Ablation Catheter 109

6.17 Jan 23, 2020: Vulnerability disclosure regarding GE Healthcare monitoring products 109

6.18 Jan 23, 2020: GE Healthcare to move as many as 250 jobs from Wisconsin 111

6.19 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 111

6.20 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 112

6.21 Dec 19, 2019: Affera announces world's first successful focal pulsed field ablation in patients 113

6.22 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 113

6.23 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 114

6.24 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 115

6.25 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 117

6.26 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 118

6.27 Oct 31, 2019: CathVision Rrceives competitive EU Grant 119

6.28 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 119

6.29 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 121

7 Appendix 123

7.1 Methodology 123

7.2 About GlobalData 127

7.3 Contact Us 127

List of Tables

Table 1: Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 10

Table 2: Electrophysiology Ablation Catheters – Pipeline Products by Segment 11

Table 3: Electrophysiology Ablation Catheters – Pipeline Products by Territory 12

Table 4: Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 13

Table 5: Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 14

Table 6: Electrophysiology Ablation Catheters – Ongoing Clinical Trials 15

Table 7: Electrophysiology Ablation Catheters Companies – Pipeline Products by Stage of Development 16

Table 8: Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 18

Table 9: Abbott Electrophysiology Pipeline Products & Ongoing Clinical Trials Overview 20

Table 10: TactiFlex SE – Product Status 20

Table 11: TactiFlex SE – Product Description 20

Table 12: Abbott Electrophysiology – Ongoing Clinical Trials Overview 21

Table 13: TactiFlex SE – Safety and Effectiveness of TactiFlex Ablation Catheter, Sensor Enabled (TactiFlex SE) for the Treatment of Drug Refractory, Symptomatic, Paroxysmal Atrial Fibrillation 22

Table 14: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 15: Ablasense – Product Status 23

Table 16: Ablasense – Product Description 23

Table 17: Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 18: LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Status 24

Table 19: LUMINIZE Radiofrequency (RF) Balloon Catheter – Product Description 24

Table 20: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 21: CARTO SMARTTOUCH 5D Catheter – Product Status 25

Table 22: CARTO SMARTTOUCH 5D Catheter – Product Description 25

Table 23: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter – Product Status 26

Table 24: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter – Product Description 26

Table 25: THERMOCOOL SMARTTOUCH SF-5D Catheter – Product Status 26

Table 26: THERMOCOOL SMARTTOUCH SF-5D Catheter – Product Description 27

Table 27: Biosense Webster Inc – Ongoing Clinical Trials Overview 28

Table 28: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter – Safety and Effectiveness Evaluation of the Multi-electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation: STELLAR 29

Table 29: THERMOCOOL SMARTTOUCH SF-5D Catheter – Acute Performance Evaluation of the QDOT Micro Catheter Used with nGEN Generator in Treatment of Patients with Atrial Fibrillation 30

Table 30: THERMOCOOL SMARTTOUCH SF-5D Catheter – Evaluation of QDOT Micro Catheter for Pulmonary Vein Isolation (PVI) in Subjects with PAF 30

Table 31: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 32: Cooled Tip Catheter – Product Status 31

Table 33: Cooled Tip Catheter – Product Description 31

Table 34: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 32

Table 35: Force Sensing Afib Catheter – Product Status 32

Table 36: Force Sensing Afib Catheter – Product Description 33

Table 37: Intellanav Stablepoint – Product Status 33

Table 38: Intellanav Stablepoint – Product Description 33

Table 39: Next Generation Blazer Catheter – Product Status 34

Table 40: Next Generation Blazer Catheter – Product Description 34

Table 41: Next Generation IntellaTip Catheter – Product Status 34

Table 42: Next Generation IntellaTip Catheter – Product Description 35

Table 43: POLARx Next Generation Catheter – Product Status 35

Table 44: POLARx Next Generation Catheter – Product Description 35

Table 45: POLARx Single Shot Cryoballoon – Product Status 36

Table 46: POLARx Single Shot Cryoballoon – Product Description 36

Table 47: Boston Scientific Corp – Ongoing Clinical Trials Overview 37

Table 48: POLARx Single Shot Cryoballoon – POLARx Cardiac Cryoablation System Post Market Clinical Follow-up Study 38

Table 49: POLARx Single Shot Cryoballoon – Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation 38

Table 50: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 51: Electrophysiology Catheter – Atrial Fibrillation – Product Status 39

Table 52: Electrophysiology Catheter – Atrial Fibrillation – Product Description 39

Table 53: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 40

Table 54: Desai VectorCathRF1 Mapping And Ablation Catheter – Product Status 40

Table 55: Desai VectorCathRF1 Mapping And Ablation Catheter – Product Description 40

Table 56: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Table 57: CathRx 4mm Therapeutic Catheter – Product Status 41

Table 58: CathRx 4mm Therapeutic Catheter – Product Description 41

Table 59: CathRx 8mm Therapeutic Catheter – Product Status 42

Table 60: CathRx 8mm Therapeutic Catheter – Product Description 42

Table 61: Khelix Irrigated Ablation EP Catheter – Product Status 42

Table 62: Khelix Irrigated Ablation EP Catheter – Product Description 43

Table 63: Khelix Non-Irrigated Ablation EP Catheter – Product Status 43

Table 64: Khelix Non-Irrigated Ablation EP Catheter – Product Description 43

Table 65: Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 66: Catheter-Based Carotid Body Ablation System – Product Status 44

Table 67: Catheter-Based Carotid Body Ablation System – Product Description 44

Table 68: Cibiem Inc – Ongoing Clinical Trials Overview 45

Table 69: Catheter-Based Carotid Body Ablation System – First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study 46

Table 70: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 47

Table 71: Optically-Integrated RFA Catheter – Product Status 47

Table 72: Optically-Integrated RFA Catheter – Product Description 47

Table 73: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 48

Table 74: EP Contact Force Sensing Catheter Enabled By CARTO 3 – Product Status 48

Table 75: EP Contact Force Sensing Catheter Enabled By CARTO 3 – Product Description 48

Table 76: CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Table 77: Electrophysiology Mapping System – Atrial Fibrillation – Product Status 49

Table 78: Electrophysiology Mapping System – Atrial Fibrillation – Product Description 49

Table 79: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 50

Table 80: FrostBite – Product Status 50

Table 81: FrostBite – Product Description 51

Table 82: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 52

Table 83: Cryotherapy System – Coronary Artery Disease – Product Status 52

Table 84: Cryotherapy System – Coronary Artery Disease – Product Description 52

Table 85: Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53

Table 86: Epicardial Access Device – Product Status 53

Table 87: Epicardial Access Device – Product Description 53

Table 88: Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

Table 89: B-Laser – CAD – Product Status 54

Table 90: B-Laser – CAD – Product Description 54

Table 91: Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Table 92: Endo FARAFLEX – Product Status 55

Table 93: Endo FARAFLEX – Product Description 55

Table 94: Endo Farapoint – Product Status 56

Table 95: Endo Farapoint – Product Description 56

Table 96: Endo Farawave – Product Status 56

Table 97: Endo Farawave – Product Description 57

Table 98: Epi Faraone – Product Status 57

Table 99: Epi Faraone – Product Description 57

Table 100: Farapulse Inc – Ongoing Clinical Trials Overview 58

Table 101: Endo Farawave – A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial Fibrillation: PEFCAT 59

Table 102: Endo Farawave – Feasibility Study of the FARAPULSE Endocardial Ablation System in the Treatment of Persistent Atrial Fibrillation: PersAFOne 59

Table 103: Endo Farawave – PEFCAT II: Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial Fibrillation 59

Table 104: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 60

Table 105: Anti-coagulum Cardiac Ablation Catheter – Product Status 60

Table 106: Anti-coagulum Cardiac Ablation Catheter – Product Description 60

Table 107: Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 61

Table 108: Hybrid Ablation Catheter – Product Status 61

Table 109: Hybrid Ablation Catheter – Product Description 61

Table 110: Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Table 111: Vision MR Ablation Catheter – Product Status 62

Table 112: Vision MR Ablation Catheter – Product Description 62

Table 113: Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63

Table 114: Atrial Fibrillation Catheter – Product Status 63

Table 115: Atrial Fibrillation Catheter – Product Description 63

Table 116: Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 64

Table 117: MaPP-CS – Product Status 64

Table 118: MaPP-CS – Product Description 64

Table 119: ROF-AC – Product Status 65

Table 120: ROF-AC – Product Description 65

Table 121: ROF-AS – Product Status 65

Table 122: ROF-AS – Product Description 66

Table 123: Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 67

Table 124: Maestro-AF Catheter System – Product Status 67

Table 125: Maestro-AF Catheter System – Product Description 67

Table 126: Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 68

Table 127: AblaView – Product Status 68

Table 128: AblaView – Product Description 68

Table 129: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 69

Table 130: DiamondTemp Ablation System – Product Status 69

Table 131: DiamondTemp Ablation System – Product Description 70

Table 132: Medtronic Plc – Ongoing Clinical Trials Overview 71

Table 133: DiamondTemp Ablation System – A Prospective Clinical Evaluation of the DiamondTemp System for the Treatment of Persistent Atrial Fibrillation 72

Table 134: DiamondTemp Ablation System – A Prospective Single Arm Clinical Evaluation for the Characterization of the Safety Profile of the DiamondTemp System for Fast Treatment of Patients with Atrial Fibrillation 72

Table 135: MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Table 136: Arrhythmia Catheters – Product Status 73

Table 137: Arrhythmia Catheters – Product Description 73

Table 138: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 74

Table 139: Circular Ablation Catheter – Product Status 74

Table 140: Circular Ablation Catheter – Product Description 74

Table 141: Voyager Irrigated RF Ablation Catheter – Product Status 75

Table 142: Voyager Irrigated RF Ablation Catheter – Product Description 75

Table 143: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 76

Table 144: Cardiac Catheter – Product Status 76

Table 145: Cardiac Catheter – Product Description 76

Table 146: Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Table 147: Electroactive Polymer Based Steerable Catheter – Product Status 77

Table 148: Electroactive Polymer Based Steerable Catheter – Product Description 77

Table 149: S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 78

Table 150: Sotera – Atrial Fibrillation Device – Product Status 78

Table 151: Sotera – Atrial Fibrillation Device – Product Description 78

Table 152: SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79

Table 153: Atrial Fibrillation Device – Product Status 79

Table 154: Atrial Fibrillation Device – Product Description 79

Table 155: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 80

Table 156: Ablation Catheter – Heart Arrhythmia – Product Status 80

Table 157: Ablation Catheter – Heart Arrhythmia – Product Description 80

Table 158: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 81

Table 159: FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Status 81

Table 160: FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Product Description 82

Table 161: St. Jude Medical LLC – Ongoing Clinical Trials Overview 83

Table 162: FlexAbility Irrigated Ablation Catheter Sensor Enabled – Monomorphic Ventricular Tachycardia – Flexability Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study 84

Table 163: Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 85

Table 164: Magnetic Ablation Catheter – Product Status 85

Table 165: Magnetic Ablation Catheter – Product Description 85

Table 166: Next Generation Irrigated Magnetic Catheter – Product Status 86

Table 167: Next Generation Irrigated Magnetic Catheter – Product Description 86

Table 168: University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 87

Table 169: Robotic Catheter – Product Status 87

Table 170: Robotic Catheter – Product Description 87

Table 171: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 88

Table 172: Non-Contact Mapping Catheter – Product Status 88

Table 173: Non-Contact Mapping Catheter – Product Description 88

Table 174: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 89

Table 175: RF Ablation Catheter – Product Status 89

Table 176: RF Ablation Catheter – Product Description 89

Table 177: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 90

Table 178: Ablation Catheter – Product Status 90

Table 179: Ablation Catheter – Product Description 91

Table 180: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 92

Table 181: Temperature Controlled Catheter – Product Status 92

Table 182: Temperature Controlled Catheter – Product Description 92

Table 183: Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 93

Table 184: Vimecon Laser CAI Catheter – Product Status 93

Table 185: Vimecon Laser CAI Catheter – Product Description 93

Table 186: Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 94

Table 187: Catheter Guidance System – Product Status 94

Table 188: Catheter Guidance System – Product Description 94

Table 189: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95

Table 190: IRIS Ablation System – Product Status 95

Table 191: IRIS Ablation System – Product Description 95

Table 192: Glossary 126

List of Figures

Figure 1: Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 10

Figure 2: Electrophysiology Ablation Catheters – Pipeline Products by Segment 11

Figure 3: Electrophysiology Ablation Catheters – Pipeline Products by Territory 12

Figure 4: Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 13

Figure 5: Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 14

Figure 6: Electrophysiology Ablation Catheters – Ongoing Clinical Trials 15

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports